Press Releases

2018

June 07, 2018 Aduro Biotech Announces Initiation of Phase 1b Clinical Trial in Non-Small Cell Lung Cancer under Janssen Strategic Partnership for ADU-214 in Combination with Nivolumab


May 10, 2018 Aduro Biotech to Present at the Bank of America Merrill Lynch 2018 Health Care Conference


May 02, 2018 Aduro Biotech Reports First Quarter 2018 Financial Results


April 26, 2018 Aduro Biotech Presents Early Observations From its Personalized Neoantigen-based pLADD Therapy Clinical Study at European Neoantigen Summit


April 17, 2018 Aduro Biotech Highlights Preclinical Data for Three Programs Reported at the American Association for Cancer Research Annual Meeting


April 02, 2018 Aduro Biotech to Present at the H.C. Wainwright Annual Global Life Sciences Conference


March 14, 2018 Aduro Biotech Announces Upcoming Data Presentations at the 2018 American Association for Cancer Research Annual Meeting


March 14, 2018 Aduro Biotech to Present at the 28th Annual Oppenheimer Healthcare Conference


March 07, 2018 Aduro Biotech to Present at the 38th Annual Cowen Healthcare Conference


March 05, 2018 Aduro Announces Milestone Achieved under Merck Collaboration for Initiation of Anti-CD27 Phase I Trial in Advanced Solid Tumors


March 05, 2018 Aduro Biotech Appoints Hans van Eenennaam Executive Vice President Antibody Research and Site Head, Aduro Biotech Europe


March 01, 2018 Aduro Biotech Announces Fourth Quarter and Full Year 2017 Financial Results


February 08, 2018 Aduro Biotech to Present at the Leerink Partners 7th Annual Global Healthcare Conference


January 05, 2018 Aduro Biotech Announces Management Changes


January 04, 2018 Aduro Biotech to Present at the 36th Annual J.P. Morgan Healthcare Conference